Paphon Sa-ngasoongsongNoratep KulachoteNorachart SirisreetreeruxPongsthorn ChanplakornSukij LaohajaroensombatNithiwut PinsiranonPatarawan WoratanaratViroj KawinwonggowitChanyut SuphachatwongWiwat WajanavisitMahidol University2018-11-232018-11-232015-01-01World Journal of Orthopaedics. Vol.6, No.11 (2015), 970-976221858362-s2.0-84952318613https://repository.li.mahidol.ac.th/handle/20.500.14594/36722© The Author(s) 2015. AIM: To investigate the effect of early surgical intervention on the high surgical risk elderly patients who sustained femoral neck fracture (FNF) and taking concomitant antiplatelet agents. METHODS: Between 2010 and 2012, a prospective study was conducted on 49 geriatric patients, who took antiplatelet agents, sustained FNF and underwent surgery within 72 h [early surgery (ES) group], and these were compared with a retrospective consecutive case series of patients with similar characteristics (45 cases) who had delayed surgery (DS group) after 72 h during an earlier 3-year period. Postoperative outcomes were followed for one year and compared. RESULTS: There were non-significant differences in perioperative blood loss, blood transfusion, intensive care unit requirement and postoperative mortality (P > 0.05 all). There were 2 patients (4%) in the DS group who died after surgery (P = 0.23). However, the ES group showed a significantly better postoperative outcome in terms of postoperative complications, length of hospital stay, and functional outcome (P < 0.05 all). CONCLUSION: Early hip surgery in geriatric hip fracture patients with ongoing antiplatelet treatment was not associated with a significant increase of perioperative blood loss and postoperative mortality. Moreover, ES resulted in a better postoperative surgical outcome. In early hip surgery protocol, the antiplatelet agents are discontinued and the patient is operated on within 72 h after admission, which is safe and effective for the medically fit patients.Mahidol UniversityMedicineEffect of early surgery in high surgical risk geriatric patients with femoral neck fracture and taking antiplatelet agentsArticleSCOPUS10.5312/wjo.v6.i11.970